Dosage guide · 600 mg vial

Glutathione Dosage Protocol

Reduced L-glutathione · endogenous antioxidant tripeptide

The reference protocol charts 100 mg once daily for weeks 1–2, 150 mg for weeks 3–4 and 200 mg for weeks 5–8. Mix the 600 mg vial with 2 mL bacteriostatic water for 300 mg/mL. The 100 mg start is 33.3 units (0.333 mL) on a U-100 syringe.

How oftenOnce daily

Starting dose100 mg

Start = units33.3 units

Mix2 mL BAC water

Reviewed 25 Oct 2026 · Education only, not medical advice

Glutathione 600 mg vial

Not currently stocked by Peak Peptides Australia

No product photo — this strength isn't stocked by Peak

Dosage chart How to mix Supplies Calculator About Glutathione References

01 · DOSAGE CHART

Glutathione dosage chart

Gradual daily approach · 600 mg vial + 2 mL BAC water

BAC water added

Concentration300 mg/mL

1 unit (U-100)3 mg= 0.01 mL

How oftenOnce dailySubcutaneous injection

2 mL is the mix shown in the 600 mg reference protocol, giving 300 mg/mL and 3 mg per U-100 unit.

Glutathione dosage chart for a 600 mg vial mixed with 2 mL of bacteriostatic water
Week	Daily dose	Syringe units
Weeks 1–2Start	100 mg	33.3 units0.333 mL
Weeks 3–4	150 mg	50 units0.5 mL
Weeks 5–8Maintenance	200 mg	66.7 units0.667 mL

Once daily · consistent time · subcutaneous injection

The chart follows the source's 8-week once-daily schedule.

The reference source mentions separate less-frequent maintenance options; they are not part of this daily chart.

Reference-site amounts only — this 600 mg subcutaneous protocol is not a clinically established dose or a TGA product label. Education only, not medical advice. Dose amounts adapted from Glutathione 600 mg vial dosage protocol (PeptideDosages.com); units are recalculated for the vial and mix selected above.

02 · HOW TO MIX

Mixing a 600 mg vial with 2 mL of BAC water

Using a 1 mL (100-unit) insulin syringe, 2 full draws of bacteriostatic water gives 300 mg/mL.

1
Add the water slowly
Wipe both rubber stoppers with an alcohol swab and let them dry. Draw 2 mL of bacteriostatic water and let it run slowly down the inside of the vial wall — not straight onto the powder.
2
Swirl gently
Swirl or roll the vial gently until the powder has dissolved. Give it a few minutes to settle if needed.
3
Don't shake it
Shaking can damage the peptide and cause foaming. Gentle swirling only.
4
Check it's fully clear
Only use it once it is fully clear with no particles. Label the vial with the date and 300 mg/mL, then store it in the fridge at 2–8 °C.

Full illustrated reconstitution guide

03 · SUPPLIES NEEDED

What you'll need

Counts follow the dosage chart above at the highest amount in each step, using a 600 mg vial mixed with 2 mL.

Length of protocol

6Glutathione 600 mg vials3500 mg needed in total

341 mL insulin syringesU-100, 27–31G · one per draw + one per vial mixed

2BAC water 10 mL bottles12 mL used for mixing

68Alcohol swabsSkin + stopper, every time

Plus an approved sharps container. Syringes and swabs are sold by Australian pharmacies — Peak Peptides and Pure Performance supply the bacteriostatic water.

Peak Peptides Australia Bacteriostatic water 10 mL

Bacteriostatic water 10 mLPeak Peptides Australia

Pure Performance Australia Bacteriostatic water 10 mL

Bacteriostatic water 10 mLPure Performance Australia

04 · CALCULATOR

Check a different amount

Enter your vial, water and dose to see the matching syringe units.

Concentration Calculator

Labelled Vial Amount (mg)

Verified Final Liquid Volume2 mL

Amount to Evaluate (not a recommendation)

600 mg is unusually large for a peptide vial. If you intended 0.6 mg, enter 0.6 instead.

Concentration

300.00 mg/mL

(300000 mcg/mL)

Calculated Liquid Volume

0.333 mL

Equivalent U-100 volume scale position

33.3markings (not biological IU)

Illustration of a U-100 volume scale, not preparation or injection guidance

05 · PROTOCOL DETAILS

About Glutathione

Protocol overview

Starting dose: 100 mg once daily for weeks 1–2
How it increases: 150 mg for weeks 3–4, then 200 mg for weeks 5–8
Frequency: Once daily
When to take it: At a consistent time
Protocol length: 8 weeks in the reference schedule
Common mix: 2 mL bacteriostatic water → 300 mg/mL

Storage

Before mixing: Store the lyophilised vial at −20 °C in dry, dark conditions.
After mixing: Refrigerate at 2–8 °C and protect from light; follow the formulation's validated use-by instructions.
Never: Avoid repeated freeze–thaw cycles.

How it works

Reduced glutathione, or GSH, is a naturally occurring tripeptide and an important non-enzymatic antioxidant inside mammalian cells.

It can neutralise some oxidants directly and serves as a cofactor for antioxidant and detoxification enzymes. When GSH is oxidised to GSSG, glutathione reductase can recycle it using NADPH.

Illustrated mechanism explainer

What the research shows

In a 2009 randomised, double-blind pilot in Parkinson's disease, 21 adults were assigned to 1,400 mg intravenous glutathione or placebo three times weekly for 4 weeks. The trial found no significant difference in motor-score change (P = 0.32).
A 2025 review reported that 1,200 mg intravenous glutathione twice weekly for 6 weeks produced temporary skin-lightening reports in 37.5% of participants versus 18.7% with placebo; the review also reported adverse events in 32% of treated participants.
The TGA ARTG lists a medicine named Glutathione under ARTG ID 232323, dated 24 December 2014. That register entry does not establish this 600 mg reconstituted-vial schedule as a product label.
CDC states that no FDA-approved glutathione drug product exists in the United States. In its 2026 investigation, CDC had reports of more than 25 illnesses across at least 4 states after injectable glutathione; at least 3 people were hospitalised.

Reported side effects

The 4-week Parkinson's pilot reported no withdrawals because of adverse events and similar reported adverse events in the glutathione and placebo groups; this small intravenous trial cannot establish safety for other formulations or schedules.
The 2025 review reported that 32% of people given 1,200 mg intravenously twice weekly for 6 weeks had adverse events, including liver dysfunction and 1 anaphylaxis case.
FDA reported 7 people who received 1,400 mg intravenous compounded glutathione and developed reactions within minutes, including nausea, vomiting, chills, body aches, low blood pressure and breathing difficulty; testing found some endotoxin results up to 5 times the appropriate limit.

Important notes

The chart dose comes from an educational reference site, not a clinical dose label. It must not be treated as an established subcutaneous dose.
The TGA says glutathione used in IV drips is a Schedule 4 prescription medicine, and public advertising of IV drips or injections containing glutathione is prohibited.
CDC states there is no FDA-approved glutathione drug product in the United States. The existence of the Australian ARTG entry does not make this 600 mg research-vial protocol a TGA product label.
FDA and CDC warn that dietary-supplement-grade glutathione must not be used for sterile injectable products because contaminants including endotoxins can cause severe reactions.
Never use a mixed vial that is cloudy or has particles in it.

Injection basics

Use a new sterile 1 mL (100-unit) U-100 insulin syringe, 27–31G, every time — never reuse or share.
Wipe the vial stopper and the skin with an alcohol swab and let both dry first.
Inject under the skin (subcutaneously) of the abdomen, thigh or upper arm, and rotate sites.
Put used syringes straight into an approved sharps container — the NDSS lists Australian disposal options.

Guidance: World Health Organization · National Diabetes Services Scheme (NDSS)

06 · QUICK ANSWERS